Merrimack Pharmaceuticals
MACK
$14.98
Share price
1.63%
Change (1 day)
18.98%
Change (1 year)
Categories
EPS for Merrimack Pharmaceuticals (MACK)
EPS in 2023 (TTM): -$0.11
According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.11. In 2022 the company made an earnings per share (EPS) of -$0.11 an increase over its 2021 EPS that were of -$0.18.
EPS history for Merrimack Pharmaceuticals from 2010 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.11 | -0% |
| 2022 | -$0.11 | -38.89% |
| 2021 | -$0.18 | -25% |
| 2020 | -$0.24 | -81.54% |
| 2019 | -$1.30 | -56.95% |
| 2018 | -$3.02 | -108.5% |
| 2017 | $35.51 | -390.35% |
| 2016 | -$12.23 | -7.35% |
| 2015 | -$13.20 | 65% |
| 2014 | -$8.00 | -39.39% |
| 2013 | -$13.20 | -54.01% |
| 2012 | -$28.70 | -53.71% |
| 2011 | -$62.00 | 40.37% |
| 2010 | -$44.17 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $3.18 | -2,991.14% | 🇫🇷 France |
 Geron GERN | -$0.34 | 209.09% | 🇺🇸 USA |
 Clovis Oncology CLVS | -$1.89 | 1,618.18% | 🇺🇸 USA |
 AVEO Oncology
AVEO | -$0.84 | 663.64% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$5.64 | 5,027.27% | 🇺🇸 USA |